Patents by Inventor Yoshikazu Nagae
Yoshikazu Nagae has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210402664Abstract: A silicone embossing rubber roller has no fine depression defects on the surface and, furthermore, is not liable to produce protrusions on an embossed plastic film surface. The silicone rubber roller is such that the silicone rubber layer on the surface contains spherical solid particles, and the spherical solid particles having a particle size of 0.8 ?m or smaller and the spherical solid particles having a particle size of 30 ?m or larger respectively occupy 1% or less of the volume of all the spherical solid particles.Type: ApplicationFiled: September 13, 2019Publication date: December 30, 2021Inventors: Yoshikazu Nagae, Yuuka Tomita, Tadashi Matsumoto
-
Publication number: 20130149525Abstract: A surface protection film has moderate adhesive properties for bonding to adherend bodies with a rough surface, a rear surface with good slipping properties, and blocking resistance and good unwinding properties. The surface protection film has a laminated structure formed at least of an adhesive layer and a back layer, wherein the adhesive layer is formed mainly of a styrene-based elastomer while the back layer is formed mainly of a propylene-based resin containing 0.5 wt % to 10 wt % of a fluorine-containing compound having a polyfluorohydrocarbon group and a polyoxy ethylene group.Type: ApplicationFiled: March 10, 2011Publication date: June 13, 2013Applicant: TORAY ADVANCED FILM CO., LTD.Inventors: Yoshikazu Nagae, Junya Satou, Shiro Imai
-
Publication number: 20130011614Abstract: A surface protection film has moderate adhesive properties for adherend bodies with a rough surface, has a rear surface with good slipping properties, and blocking resistance and good unwinding properties (decreased unwinding tension to enable easy, high-speed sticking of the film to an adherend without causing creases or flaws). The surface protection film has a three-layered composite structure including an adhesive layer, an interlayer, and a back layer, wherein the adhesive layer is formed of 35 to 90 wt % of a linear low density polyethylene, 5 to 50 wt % of a styrene-based elastomer, and 15 wt % or less of a tackifier, the interlayer formed mainly of a propylene-based resin, and the back layer formed mainly of the same propylene-based resin as that constituting the interlayer and/or a different propylene-based resin therefrom, and also wherein the back layer has a surface roughness of 3 ?m or more in terms of ten-point average roughness (Rz).Type: ApplicationFiled: March 10, 2011Publication date: January 10, 2013Applicant: TORAY ADVANCED FILM CO., LTD.Inventors: Yoshikazu Nagae, Junya Satou, Miyuki Tokumaru, Shiro Imai
-
Patent number: 7803807Abstract: The present invention relates to compounds of Formula (I) wherein A, B and C are independently methine, said methine being optionally substituted; D is nitrogen; T, U, V and W are independently methine or nitrogen, said methine being optionally substituted and least two of T, U, V and W are said methine groups; X is —N(SO2R4)—, N(COR5)— or —CO—; Y is C(R6)(R7)—, —O— or —N(R8) and a pharmaceutically acceptable salt, ester or N-oxide derivative thereof.Type: GrantFiled: October 26, 2009Date of Patent: September 28, 2010Assignee: Banyu Pharmaceutical Co., Ltd.Inventors: Norikazu Otake, Minoru Moriya, Yoshio Ogino, Kenji Matsuda, Yoshikazu Nagae, Akio Kanatani, Takehiro Fukami
-
Patent number: 7728025Abstract: A glucokinase activator is provided; and a remedy and/or a preventive for diabetes, or a remedy and/or a preventive for diabetes such as retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis, and further a remedy and/or a preventive for obesity are provided. A glucokinase activator characterized by containing a 2-heteroaryl-substituted benzimidazole derivative of a general formula (I-0) or its pharmaceutically-acceptable salt: [in the formula, X represents a carbon atom or a nitrogen atom; X1, X2, X3 and X4 each independently represent a carbon atom or a nitrogen atom; the ring A represents a 5- or 6-membered nitrogen-containing aromatic hetero ring of a formula (II): (in the formula, X represents a carbon atom or a nitrogen atom); R1 represents an aryl, etc.; R2 represents a hydroxy, etc.; R3 represents a —C1-6 alkyl, etc.; R4 represents a —C1-6 alkyl, etc.; X5 represents —O—, etc.Type: GrantFiled: December 28, 2004Date of Patent: June 1, 2010Assignee: Banyu Pharmaceutical Co., Ltd.Inventors: Katsumasa Nonoshita, Makoto Ishikawa, Hiroshi Nakashima, Daisuke Tsukahara, Yoshio Ogino, Fumiko Sakai, Yoshikazu Nagae, Keisuke Arakawa, Teruyuki Nishimura
-
Patent number: 7687514Abstract: The present invention relates to a compound of the formula (I): (wherein A, B, C and D are independently nitrogen or optionally substituted methine; E is nitrogen, methine or hydroxy substituted methine; n is 0 or 1; T, U, V and W are independently nitrogen or optionally substituted methine; X is —N(SO2R4)—, —N(COR5)— or —CO—; Y is —C(R6)(R7)—, —O— or —N(R8)—, provided that the compound (I) when E is nitrogen, n is 0, X is —CO—, and Y is —O— is excluded) and the like, which are useful as an agent for the treatment of various diseases related to NPY.Type: GrantFiled: May 10, 2006Date of Patent: March 30, 2010Assignee: Banyu Pharmaceuticals Co., Ltd.Inventors: Norikazu Otake, Minoru Moriya, Yoshio Ogino, Kenji Matsuda, Yoshikazu Nagae, Akio Kanatani, Takehiro Fukami
-
Publication number: 20100048600Abstract: The present invention relates to a compound of the formula (I): (wherein A, B, C and D are independently nitrogen or optionally substituted methine; E is nitrogen, methine or hydroxy substituted methine; n is 0 or 1; T, U, V and W are independently nitrogen or optionally substituted methine; X is —N(SO2R4)—, —N(COR5)— or —CO—; Y is —C(R6)(R7)—, —O— or —N(R8)—, provided that the compound (I) when E is nitrogen, n is 0, X is —CO—, and Y is —O— is excluded) and the like, which are useful as an agent for the treatment of various diseases related to NPY, for example cardiovascular disorders such as angina, acute or congestive heart failure, myocardial infarction, hypertension, nephropathy, electrolyte abnormality, vasospasm, arteriosclerosis, etc., central nervous system disorders such as bulimia, depression, anxiety, seizure, epilepsy, dementia, pain, alcoholism, drug withdrawal, circadian rhythm disorders, schizophrenia, memory impairment, sleep disorders, cognitive impairment, etc.Type: ApplicationFiled: October 26, 2009Publication date: February 25, 2010Inventors: NORIKAZU OTAKE, Minoru Moriya, Yoshio Ogino, Kenji Matsuda, Yoshikazu Nagae, Akio Kanatani, Takehiro Fukami
-
Publication number: 20080070928Abstract: A glucokinase activator is provided; and a remedy and/or a preventive for diabetes, or a remedy and/or a preventive for diabetes such as retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis, and further a remedy and/or a preventive for obesity are provided. A glucokinase activator characterized by containing a 2-heteroaryl-substituted benzimidazole derivative of a general formula (I-0) or its pharmaceutically-acceptable salt: [in the formula, X represents a carbon atom or a nitrogen atom; X1, X2, X3 and X4 each independently represent a carbon atom or a nitrogen atom; the ring A represents a 5- or 6-membered nitrogen-containing aromatic hetero ring of a formula (II): (in the formula, X represents a carbon atom or a nitrogen atom); R1 represents an aryl, etc.; R2 represents a hydroxy, etc.; R3 represents a —C1-6 alkyl, etc.; R4 represents a —C1-6 alkyl, etc.; X5 represents —O—, etc.Type: ApplicationFiled: December 28, 2004Publication date: March 20, 2008Inventors: Katsumasa Nonoshita, Makoto Ishikawa, Hiroshi Nakashima, Daisuke Tsukahara, Yoshio Ogino, Fumiko Sakai, Yoshikazu Nagae, Keisuke Arakawa, Teruyuki Nishimura, Jun-Ichi Eiki
-
Publication number: 20060205750Abstract: The present invention relates to a compound of the formula (I): (wherein A, B, C and D are independently nitrogen or optionally substituted methine; E is nitrogen, methine or hydroxy substituted methine; n is 0 or 1; T, U, V and W are independently nitrogen or optionally substituted methine; X is —N(SO2R4)—, —N(COR5)— or —CO—; Y is —C(R6)(R7)—, —O— or —N(R8)—, provided that the compound (I) when E is nitrogen, n is 0, X is —CO—, and Y is —O— is excluded) and the like, which are useful as an agent for the treatment of various diseases related to NPY, for example cardiovascular disorders such as angina, acute or congestive heart failure, myocardial infarction, hypertension, nephropathy, electrolyte abnormality, vasospasm, arteriosclerosis, etc., central nervous system disorders such as bulimia, depression, anxiety, seizure, epilepsy, dementia, pain, alcoholism, drug withdrawal, circadian rhythm disorders, schizophrenia, memory impairment, sleep disorders, cognitive impairment, etc.Type: ApplicationFiled: May 10, 2006Publication date: September 14, 2006Inventors: Norikazu Otake, Minoru Moriya, Yoshio Ogino, Kenji Matsuda, Yoshikazu Nagae, Akio Kanatani, Takehiro Fukami
-
Patent number: 7105526Abstract: The present invention relates to novel benzimidazole derivatives which are useful as neuropeptide Y receptor antagonists.Type: GrantFiled: June 18, 2003Date of Patent: September 12, 2006Assignee: Banyu Pharmaceuticals Co., Ltd.Inventors: Norikazu Otake, Minoru Moriya, Yoshio Ogino, Kenji Matsuda, Yoshikazu Nagae, Akio Kanatani, Takehiro Fukami
-
Publication number: 20040054177Abstract: The present invention relates to a compound of the formula (I): 1Type: ApplicationFiled: June 18, 2003Publication date: March 18, 2004Inventors: Norikazu Otake, Minoru Moriya, Yoshio Ogino, Kenji Matsuda, Yoshikazu Nagae, Akio Kanatani, Takehiro Fukami